World Journal of Cardiovascular Diseases
Vol.2 No.4(2012), Paper ID 23703, 9
pages
DOI:10.4236/wjcd.2012.24042
The rationale and design of the minocycline plus amiodarone versus amiodarone alone (MINAA) trial for the prevention of atrial fibrillation after cardiac surgery
Abdallah Khaled Alameddine, Paul Visintainer, Victor Alimov, Jennifer Germain, Yvonne A. Alameddine, Daniel Engelman, John A. Rousou
Divisions of Cardiac Surgery, Baystate Medical Center, Springfield, USA
The Department of Epidemiology and Academic Affairs, Springfield, USA
Divisions of Cardiac Surgery, Baystate Medical Center, Springfield, USA
Divisions of Cardiac Surgery, Baystate Medical Center, Springfield, USA
Divisions of Cardiac Surgery, Baystate Medical Center, Springfield, USA
Divisions of Cardiac Surgery, Baystate Medical Center, Springfield, USA
Divisions of Cardiac Surgery, Baystate Medical Center, Springfield, USA
Copyright © 2012 Abdallah Khaled Alameddine, Paul Visintainer, Victor Alimov, Jennifer Germain, Yvonne A. Alameddine, Daniel Engelman, John A. Rousou et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
Alameddine, A. , Visintainer, P. , Alimov, V. , Germain, J. , Alameddine, Y. , Engelman, D. and Rousou, J. (2012) The rationale and design of the minocycline plus amiodarone versus amiodarone alone (MINAA) trial for the prevention of atrial fibrillation after cardiac surgery.
World Journal of Cardiovascular Diseases,
2, 269-276. doi:
10.4236/wjcd.2012.24042.